Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q3 EPS of ($0.50), $0.14 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.